Tianjin Chase Sun Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 42.59% vs -41.45% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 198.42% vs -1,054.79% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,130.20",
          "val2": "792.60",
          "chgp": "42.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "84.20",
          "val2": "65.50",
          "chgp": "28.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "4.90",
          "chgp": "-20.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-39.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "68.60",
          "val2": "-69.70",
          "chgp": "198.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "74.50%",
          "val2": "-29.40%",
          "chgp": "10.39%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -14.67% vs -5.42% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.06% vs -95.43% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,901.80",
          "val2": "5,744.80",
          "chgp": "-14.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "523.20",
          "val2": "446.80",
          "chgp": "17.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "24.20",
          "val2": "48.60",
          "chgp": "-50.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-64.70",
          "val2": "-37.30",
          "chgp": "-73.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "22.20",
          "val2": "22.90",
          "chgp": "-3.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.50%",
          "val2": "13.60%",
          "chgp": "1.99%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,130.20

792.60

42.59%

Operating Profit (PBDIT) excl Other Income

84.20

65.50

28.55%

Interest

3.90

4.90

-20.41%

Exceptional Items

0.00

-39.60

100.00%

Consolidate Net Profit

68.60

-69.70

198.42%

Operating Profit Margin (Excl OI)

74.50%

-29.40%

10.39%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 42.59% vs -41.45% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 198.42% vs -1,054.79% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,901.80

5,744.80

-14.67%

Operating Profit (PBDIT) excl Other Income

523.20

446.80

17.10%

Interest

24.20

48.60

-50.21%

Exceptional Items

-64.70

-37.30

-73.46%

Consolidate Net Profit

22.20

22.90

-3.06%

Operating Profit Margin (Excl OI)

33.50%

13.60%

1.99%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -14.67% vs -5.42% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -3.06% vs -95.43% in Dec 2024

All Annual Results